Skip to content

Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers

A Feasibility Study of Retinal Screening Using the RetinaVue 100 Hand- Held (Non-mydriatic) Camera in Outpatient Dialysis Centers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02823600
Enrollment
68
Registered
2016-07-06
Start date
2016-07-31
Completion date
2017-05-31
Last updated
2018-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy, Eye Diseases, Kidney Failure, Chronic

Keywords

retinal screening, outpatient dialysis

Brief summary

The purpose of this research study is to look at retinal abnormalities in outpatient renal dialysis patients using the FDA approved RetinaVue 100 hand-held (non-mydriatic) camera.

Detailed description

There are no studies evaluating (diabetic or non-diabetic) retinopathy in the renal dialysis patient population (\ 300,000 Americans). Approximately 50% of this population has End-stage Retinal Disease (ESRD) due to diabetes. Dialysis patients are among the most debilitated patients, and thus, have even more barriers to receiving their recommended annual retinal evaluation. The advent of the RetinaVue hand-held retinal camera holds great promise in this population, as dialysis patients access medical care 3 times a week, for several hours at a time at their dialysis clinic.

Interventions

DEVICERetinaVue 100 camera

Images of the subject's eye will be obtained using the RetinaVue 100 camera and uploaded to a secure network. The study doctor, a board-certified ophthalmologist, will interpret the patient images and return a diagnosis and management plan to the dialysis unit.

Sponsors

Welch Allyn
CollaboratorINDUSTRY
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The subject must currently be seeking treatment for end-stage renal disease (ESRD) at one of the specified dialysis clinics. * The subject must be ≥ 18 years of age.

Exclusion criteria

* The subject is \<18 years of age. * No exclusions will be made on the basis of gender, ethnicity, or race.

Design outcomes

Primary

MeasureTime frameDescription
Usability of the RetinaVue Hand-Held 100 Camerabaseline visitUsability of RetinaVue camera assessed by determining the number and percentage of inadequate images and the number and percentage of adequate images.

Secondary

MeasureTime frameDescription
Overall Retinopathy in a Dialysis PopulationPost retinal eye examNumber of participants found to have retinopathy in a dialysis population
Participant SatisfactionPost retinal eye examParticipant satisfaction survey data to be collected following the completion of retinal eye exam. Participants will be assessed on participant satisfaction measures such as comfort of experience, recovery time, and time invested in undergoing procedure vs. traditional retinal exam methods. The survey utilized a five-point Likert scale with the following responses: (1) strongly agree, (2) agree, (3) neutral, (4) disagree, (5) strongly disagree. The outcome measure is reported percentages for each of the six survey components.
Pre-and Post-eye Exam Rates in the Diabetic Dialysis PopulationBaseline and post retinal eye examChanges in eye exam rates of the diabetic subset of total population from baseline (i.e. study entry) and post-enrollment in study. Baseline data were to be obtained from the UNC electronic medical record (EMR) as the number of participants with eye exams within the past year and post data would consist of the number of participants completing a study exam.

Countries

United States

Participant flow

Participants by arm

ArmCount
RetinaVue 100 Camera
All participants will have a retinal eye exam completed by study staff using the FDA-approved RetinaVue 100 hand-held camera
68
Total68

Baseline characteristics

CharacteristicRetinaVue 100 Camera
Age, Customized
No retinopathy
54.7 years
STANDARD_DEVIATION 18.1
Age, Customized
Retinopathy without referral
60.0 years
STANDARD_DEVIATION 6.6
Age, Customized
Retinopathy with referral
57.1 years
STANDARD_DEVIATION 11.6
Diabetic dialysis population
Diabetes: No
31 Participants
Diabetic dialysis population
Diabetes: Yes
37 Participants
End-Stage Renal Disease Etiology
Data Missing
7 Participants
End-Stage Renal Disease Etiology
Diabetes: No retinopathy
7 Participants
End-Stage Renal Disease Etiology
Diabetes: Retinopathy without referral
8 Participants
End-Stage Renal Disease Etiology
Diabetes: Retinopathy with referral
13 Participants
End-Stage Renal Disease Etiology
Hypertension: No retinopathy
12 Participants
End-Stage Renal Disease Etiology
Hypertension: Retinopathy without referral
1 Participants
End-Stage Renal Disease Etiology
Hypertension: Retinopathy with referral
7 Participants
End-Stage Renal Disease Etiology
Other: No retinopathy
13 Participants
End-Stage Renal Disease Etiology
Other: Retinopathy without referral
2 Participants
End-Stage Renal Disease Etiology
Other: Retinopathy with referral
4 Participants
Race/Ethnicity, Customized
African American: No retinopathy
14 Participants
Race/Ethnicity, Customized
African American: Retinopathy without referral
6 Participants
Race/Ethnicity, Customized
African American: Retinopathy with referral
11 Participants
Race/Ethnicity, Customized
Caucasian: No retinopathy
11 Participants
Race/Ethnicity, Customized
Caucasian: Retinopathy without referral
3 Participants
Race/Ethnicity, Customized
Caucasian: Retinopathy with referral
8 Participants
Race/Ethnicity, Customized
Data Missing
1 Participants
Race/Ethnicity, Customized
Hispanic: No retinopathy
8 Participants
Race/Ethnicity, Customized
Hispanic: Retinopathy without referral
2 Participants
Race/Ethnicity, Customized
Hispanic: Retinopathy with referral
4 Participants
Sex/Gender, Customized
Female : No retinopathy
17 Participants
Sex/Gender, Customized
Female : Retinopathy without referral
6 Participants
Sex/Gender, Customized
Female : Retinopathy with referral
6 Participants
Sex/Gender, Customized
Male : No retinopathy
16 Participants
Sex/Gender, Customized
Male : Retinopathy without referral
5 Participants
Sex/Gender, Customized
Male : Retinopathy with referral
18 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 68
other
Total, other adverse events
0 / 68
serious
Total, serious adverse events
0 / 68

Outcome results

Primary

Usability of the RetinaVue Hand-Held 100 Camera

Usability of RetinaVue camera assessed by determining the number and percentage of inadequate images and the number and percentage of adequate images.

Time frame: baseline visit

ArmMeasureGroupValue (COUNT_OF_UNITS)
ImagesUsability of the RetinaVue Hand-Held 100 CameraInadequate Images20 Retinal Images
ImagesUsability of the RetinaVue Hand-Held 100 CameraAdequate Images116 Retinal Images
Secondary

Overall Retinopathy in a Dialysis Population

Number of participants found to have retinopathy in a dialysis population

Time frame: Post retinal eye exam

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
ImagesOverall Retinopathy in a Dialysis PopulationNo retinopathy33 Participants
ImagesOverall Retinopathy in a Dialysis PopulationRetinopathy35 Participants
Secondary

Participant Satisfaction

Participant satisfaction survey data to be collected following the completion of retinal eye exam. Participants will be assessed on participant satisfaction measures such as comfort of experience, recovery time, and time invested in undergoing procedure vs. traditional retinal exam methods. The survey utilized a five-point Likert scale with the following responses: (1) strongly agree, (2) agree, (3) neutral, (4) disagree, (5) strongly disagree. The outcome measure is reported percentages for each of the six survey components.

Time frame: Post retinal eye exam

Population: This analysis is based on responses from the 39 that completed the survey.

ArmMeasureGroupValue (NUMBER)
ImagesParticipant SatisfactionSatisfied time complete eye exam:Disagree0 Percentage of participants
ImagesParticipant SatisfactionSatisfied time complete eye exam : Neutral10.3 Percentage of participants
ImagesParticipant SatisfactionSatisfied time complete eye exam:Strongly agree61.5 Percentage of participants
ImagesParticipant SatisfactionSatisfied time complete eye exam : Agree28.2 Percentage of participants
ImagesParticipant SatisfactionSatisfied time complete eye exam:Strongly Disagree0 Percentage of participants
ImagesParticipant SatisfactionComfort during eye exam : Strongly agree75.4 Percentage of participants
ImagesParticipant SatisfactionComfort during eye exam : Agree24.6 Percentage of participants
ImagesParticipant SatisfactionComfort during eye exam : Neutral0 Percentage of participants
ImagesParticipant SatisfactionComfort during eye exam : Disagree0 Percentage of participants
ImagesParticipant SatisfactionComfort during eye exam : Strongly Disagree0 Percentage of participants
ImagesParticipant SatisfactionComfort after eye exam : Strongly agree82.0 Percentage of participants
ImagesParticipant SatisfactionComfort after eye exam : Agree18.0 Percentage of participants
ImagesParticipant SatisfactionComfort after eye exam : Neutral0 Percentage of participants
ImagesParticipant SatisfactionComfort after eye exam : Disagree0 Percentage of participants
ImagesParticipant SatisfactionComfort after eye exam : Strongly Disagree0 Percentage of participants
ImagesParticipant Satisfaction1st eye quick recovery:Strongly agree53.9 Percentage of participants
ImagesParticipant Satisfaction1st eye quick recovery:Agree41.0 Percentage of participants
ImagesParticipant Satisfaction1st eye quick recovery:Neutral5.1 Percentage of participants
ImagesParticipant Satisfaction1st eye quick recovery:Disagree0 Percentage of participants
ImagesParticipant Satisfaction1st eye quick recovery:Strongly Disagree0 Percentage of participants
ImagesParticipant Satisfaction2nd eye quick recovery:Strongly agree59.0 Percentage of participants
ImagesParticipant Satisfaction2nd eye quick recovery:Agree35.9 Percentage of participants
ImagesParticipant Satisfaction2nd eye quick recovery:Neutral5.1 Percentage of participants
ImagesParticipant Satisfaction2nd eye quick recovery :Disagree0 Percentage of participants
ImagesParticipant Satisfaction2nd eye quick recovery:Strongly Disagree0 Percentage of participants
ImagesParticipant SatisfactionSatisfied w overall experience:Strongly agree79.5 Percentage of participants
ImagesParticipant SatisfactionSatisfied w overall experience:Agree20.5 Percentage of participants
ImagesParticipant SatisfactionSatisfied w overall experience:Neutral0 Percentage of participants
ImagesParticipant SatisfactionSatisfied w overall experience:Disagree0 Percentage of participants
ImagesParticipant SatisfactionSatisfied w overall experience:Strongly Disagree0 Percentage of participants
Secondary

Pre-and Post-eye Exam Rates in the Diabetic Dialysis Population

Changes in eye exam rates of the diabetic subset of total population from baseline (i.e. study entry) and post-enrollment in study. Baseline data were to be obtained from the UNC electronic medical record (EMR) as the number of participants with eye exams within the past year and post data would consist of the number of participants completing a study exam.

Time frame: Baseline and post retinal eye exam

Population: Baseline retinal examination data were not present within the EMR; therefore, this analysis could not be performed.

Post Hoc

Number of Diabetic Dialysis Subjects Undergoing Retinal Exam During Study Using the RetinaVue 100 Camera

Time frame: Up to as much as one year after study enrollment

Population: Diabetic dialysis participants

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ImagesNumber of Diabetic Dialysis Subjects Undergoing Retinal Exam During Study Using the RetinaVue 100 CameraNo retinopathy11 Participants
ImagesNumber of Diabetic Dialysis Subjects Undergoing Retinal Exam During Study Using the RetinaVue 100 CameraRetinopathy without referral9 Participants
ImagesNumber of Diabetic Dialysis Subjects Undergoing Retinal Exam During Study Using the RetinaVue 100 CameraRetinopathy with referral17 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026